Australian Clinical Labs falls after Healius rejects buyout bid

Australian Clinical Labs

04/05/2023 04:23

** Shares of Australian Clinical Labs  ACL.AX  fall as much
as 5% to A$3.450, set to mark worst day since March 27, if
current losses hold 
    ** Stock hits lowest since April 18  
    ** Fall comes after Australia's Healius  HLS.AX  recommended
its shareholders to reject a takeover offer by co 
    ** Healius shares are down ~1.5%   
    ** ACL has risen ~22% this year, as of last close


($1 = 1.4945 Australian dollars)

 (Reporting by Nausheen Thusoo in Bengaluru)
 ((Nausheen.Thusoo@thomsonreuters.com;))